Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Show simple item record

dc.contributor.author Eldfors, S.
dc.contributor.author Kuusanmäki, H.
dc.contributor.author Kontro, M.
dc.contributor.author Majumder, M. M.
dc.contributor.author Parsons, Alun
dc.contributor.author Edgren, H.
dc.contributor.author Pemovska, T.
dc.contributor.author Kallioniemi, O.
dc.contributor.author Wennerberg, K.
dc.contributor.author Gökbuget, N.
dc.contributor.author Burmeister, T.
dc.contributor.author Porkka, K.
dc.contributor.author Heckman, C. A.
dc.date.accessioned 2017-06-26T07:06:04Z
dc.date.available 2017-06-26T07:06:04Z
dc.date.issued 2017
dc.identifier.citation Eldfors , S , Kuusanmäki , H , Kontro , M , Majumder , M M , Parsons , A , Edgren , H , Pemovska , T , Kallioniemi , O , Wennerberg , K , Gökbuget , N , Burmeister , T , Porkka , K & Heckman , C A 2017 , ' Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia ' , Leukemia , vol. 31 , no. 1 , pp. 51-57 . https://doi.org/10.1038/leu.2016.202
dc.identifier.other PURE: 69115137
dc.identifier.other PURE UUID: 23fa7e59-d1fe-4dfe-90af-fff9f05997ea
dc.identifier.other Scopus: 84984849132
dc.identifier.other WOS: 000394058700007
dc.identifier.other ORCID: /0000-0002-5550-2951/work/41131325
dc.identifier.other ORCID: /0000-0003-4112-5902/work/39887801
dc.identifier.other ORCID: /0000-0001-5056-4750/work/34564633
dc.identifier.uri http://hdl.handle.net/10138/194786
dc.format.extent 7
dc.language.iso eng
dc.relation.ispartof Leukemia
dc.rights cc_by_nc_sa
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject 3122 Cancers
dc.title Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia en
dc.type Article
dc.contributor.organization Institute for Molecular Medicine Finland
dc.contributor.organization Clinicum
dc.contributor.organization Hematologian yksikkö
dc.contributor.organization Department of Oncology
dc.contributor.organization Department of Medicine
dc.contributor.organization Olli-Pekka Kallioniemi / Principal Investigator
dc.contributor.organization Krister Wennerberg / Principal Investigator
dc.contributor.organization HUS Comprehensive Cancer Center
dc.contributor.organization Precision Systems Medicine
dc.description.reviewstatus Peer reviewed
dc.relation.doi https://doi.org/10.1038/leu.2016.202
dc.relation.issn 0887-6924
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
leu2016202a.pdf 1.450Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record